The European Union's drug watchdog Thursday approved Moderna's anti-Covid shot for children aged six to 11, the second vaccine to be approved for younger children in the 27-member bloc.
"The EMA's human medicines committee (CHMP) has recommended granting an extension of indication for the Covid-19 vaccine Spikevax to include use in children aged 6 to 11," the Amsterdam-based European Medicines Agency said in a statement.
The jab, developed by US-based pharmaceutical company Moderna, has already been approved for adults and children aged 12 and above.
"As in the older age group, the vaccine is given as two injections in the muscles of the upper arm, four weeks apart," the EMA said.
Pfizer/BionTech's anti-Covid shot called Comirnaty was greenlit for children aged five to 11 in November.
The regulator has so far approved five vaccines for use in the EU: Pfizer and Moderna, which use messenger RNA technology, AstraZeneca and Johnson & Johnson, which use viral vector technology, and Novavax, which is based on a spike protein produced in a laboratory.
(Except for the headline, this story has not been edited by NDTV staff and is published from a syndicated feed.)
Is France Seeing Spike In Covid Cases Ahead Of Paris Olympics? What Minister Said "Critical Flaws In Methodology": Centre Slams Study On Excess Covid Deaths Britain Failed By Flawed Planning For Coronavirus Pandemic, Probe Finds At Olympics Opening Ceremony, Drag Parody Of 'The Last Supper' Draws Flak Centre Fact-Checks Mamata Banerjee's Mic-Off Claim, She Hits Back Boyfriend Stabs 20-Year-Old To Death Near Mumbai, Dumps Body In Bushes: Cops 5 Children Among 8 Killed After Car Falls Into Gorge In J&K's Anantnag Rape accused, Missing For 5 Months, Arrested In J&K's Ramban: Police "Goa Would Have Collapsed Had The Congress Rule Continued": Kiren Rijiju Track Latest News Live on NDTV.com and get news updates from India and around the world.